Publicaciones en colaboración con investigadores/as de Paris Descartes University (83)

2019

  1. A survey on the prevalence of apathy in elderly people referred to specialized memory centers

    International Journal of Geriatric Psychiatry, Vol. 34, Núm. 10, pp. 1369-1377

  2. Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

    Annals of Oncology, Vol. 30, Núm. 1, pp. 124-131

  3. Double-strand break repair through homologous recombination in autosomal-recessive BCL10 deficiency

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 5, pp. 1931-1934.e1

  4. ESC working group on cellular biology of the heart: Position paper for Cardiovascular Research: Tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure

    Cardiovascular Research, Vol. 115, Núm. 3, pp. 488-500

  5. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  6. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

  7. Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson’s Disease Patients

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 2466-2481

  8. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

    Human Mutation, Vol. 40, Núm. 9, pp. 1557-1578

  9. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911

  10. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 7, pp. 979-987

  11. Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry

    Journal of Inherited Metabolic Disease, Vol. 42, Núm. 2, pp. 333-352

  12. The European network for care of children with paediatric rheumatic diseases: Care across borders

    Rheumatology (United Kingdom), Vol. 58, Núm. 7, pp. 1188-1195

  13. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    npj Breast Cancer, Vol. 5, Núm. 1

2018

  1. Acetylome in human fibroblasts from Parkinson’s disease patients

    Frontiers in Cellular Neuroscience, Vol. 12

  2. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis

    Journal of the National Cancer Institute, Vol. 110, Núm. 6, pp. 560-567

  3. Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: A systematic review

    Journal of Psychiatry and Neuroscience, Vol. 43, Núm. 4, pp. 223-244

  4. Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) Recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine

    Circulation Research, Vol. 122, Núm. 2, pp. 199-201

  5. Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative

    Ophthalmology, Vol. 125, Núm. 5, pp. 757-773

  6. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group

    European Psychiatry, Vol. 54, pp. 71-76

  7. Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

    Clinical Microbiology and Infection, Vol. 24, Núm. 2, pp. 192-198